Finland positions itself as a European innovation hub in 'Health & Life Sciences' to attract international investment

Innovation Ecosystem

Finland is establishing itself as a strategic ecosystem for investment in the health and life sciences sector. Through the Business Finland agency, the Nordic country offers a unique collaborative environment, access to high-quality data, and cutting-edge technologies such as quantum computing to facilitate the development and commercialization of solutions in the European market.


Finland It has established itself as a key hub for investment and development in the sectors of Health & Life Sciencesoffering international companies a robust ecosystem based on reliable data, structured collaboration, and direct access to markets in the European UnionThe promotion agency Business Finland It highlights the country as a stable operating and regulatory environment, designed for clinical research, the development of health technologies and the scaling up of innovative solutions.

An innovation ecosystem based on public-private collaboration

The Finnish innovation model is based on synergy between startups, large corporations, healthcare providers, and researchers. This collaboration is not merely theoretical but is articulated through pilot projects, shared platforms, and co-development models. This approach allows companies to test new ideas, forge strategic alliances, and move from the pilot phase to commercialization more efficiently, minimizing deviations. Companies operating in Finland They can develop solutions jointly with startups and research groups, run pilot projects in real healthcare settings, and invest through investment vehicles. corporate venture capital and build long-term partnerships within an ecosystem that integrates the health, ICT and industry sectors.

Quantum computing as a differentiator for pharmaceutical discovery

One of the most disruptive elements of the Finnish value proposition is the integration of the quantum computing in life sciences research. The country has connected its quantum systems with domestic high-performance computing (HPC) resources, opening new avenues for drug discovery, molecular modeling, and complex data analysis. Public funding actively supports deep technology (deep techthrough pilot projects that demonstrate the practical value of quantum computing. This allows companies to explore quantum methods for drug discovery, combine quantum and classical computing workflows, and collaborate with research institutes and universities to build the first quantum applications in the life sciences.

Technology and digital health: a testing ground for the EU market

The highly digitized Finnish healthcare system serves as an effective testing ground for medical technology. Companies have the opportunity to work directly with hospitals, healthcare providers, and patients to validate data-driven devices, software, and services in a real-world setting. This model allows testing, integration, and regulatory readiness to occur early in development, significantly reducing barriers to product deployment across the healthcare system. European UnionThe country's strong expertise in sensors, software, and wireless systems, coupled with a growing focus on areas such as women's health, reinforces its appeal to companies in HealthTech.

Pharmaceutical and biotechnological development with access to population data

Finland It offers robust support for pharmaceutical and biotechnology projects, from initial research through clinical trials and manufacturing. Companies benefit from a highly skilled workforce, structured collaboration with healthcare providers, and access to population-level health data and biobanks. The country has a proven track record in conducting clinical trials and studies based on real-world evidence (Real-World Evidence), a competitive cost structure for R&D and manufacturing, and a public-private partnership model with hospitals and research institutes that accelerates innovation.

International agenda for attracting investment

To showcase their ecosystem, Finland will participate in two key industry events during 2026. The delegation, led by Invest in Finland y Business Finland, will seek to attract international partners and investors.

Upcoming Health & Life Sciences sector events with Finnish participation (2026)
Event Date Details of participation
Finland at NLSDays 2026 (Nordic Life Science Days) 08.09.2026 Team FinlandTogether with regional partners, it will have a stand to present the Finnish ecosystem as one of the most attractive in Europa.
Finland at Bio-Europe 2026 09.11.2026 Invest in Finland It will participate within a joint Nordic pavilion to showcase the country's strengths in research and innovation.

Coexia®

AI in the foreign trade

Hi! I'm Coexia. How can I help you today with your internationalization strategy?
Coexia AI of foreign trade